Meloxicam Zentiva (Meloxicam)

Meloxicam selectively blocks the cyclooxygenase‑2 (COX‑2) enzyme, which is responsible for producing prostaglandins that mediate inflammation, pain, and fever. By lowering prostaglandin levels, meloxicam diminishes the inflammatory cascade, providing analgesic and anti‑inflammatory effects while sparing COX‑1 activity to a greater extent.

The appropriate dose of Meloxicam Zentiva is determined by the prescribing healthcare professional based on the patient’s condition, severity, and individual risk factors. Dosage may vary, and patients should follow the prescriber’s instructions without altering the regimen on their own.

The safety of meloxicam during pregnancy has not been established, and it is generally avoided, especially in the third trimester. Breastfeeding mothers should consult their physician, as meloxicam can be excreted in breast milk and may affect the infant. Professional guidance is essential before use.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Meloxicam offers a relatively selective COX‑2 inhibition, which may result in a lower incidence of gastrointestinal irritation compared with non‑selective NSAIDs like ibuprofen or naproxen. However, cardiovascular and renal risks remain, and the choice of NSAID should be individualized based on patient comorbidities and risk profiles.

Meloxicam Zentiva should be stored at room temperature, below 25 °C (77 °F). Keep the product in its original packaging, protect it from moisture, heat, and direct sunlight to maintain stability and potency throughout its shelf life.

Meloxicam Zentiva is taken orally, usually with a full glass of water. It can be taken with or without food, but patients who experience stomach upset may benefit from taking it with meals. The exact administration schedule should follow the prescriber’s directions.

Serious risks include gastrointestinal ulceration or bleeding, cardiovascular events such as heart attack or stroke, severe liver injury, renal impairment, and rare but life‑threatening skin reactions like Stevens‑Johnson syndrome. Patients should be monitored for these events, especially if they have pre‑existing risk factors.

Meloxicam is contraindicated in patients with known hypersensitivity to meloxicam or other NSAIDs, those with active gastrointestinal bleeding or ulceration, and in the third trimester of pregnancy. Caution is also advised for individuals with severe heart failure, uncontrolled hypertension, or significant renal or hepatic impairment.